Labshake search
Citations for R&D Systems :
351 - 400 of 1098 citations for 7 METHYLTHIENO 2 3 B QUINOLINE 2 CARBOXYLIC ACID since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... supplemented with 20 ng/mL of recombinant mouse interleukin (IL)- 2 (R&D systems), 8% CTS Immune Cell Serum Replacement (Thermo Fisher) ...
-
bioRxiv - Cancer Biology 2023Quote: ... purified sheep IgG (2 mg/mL for LRIG1 R&D Systems #5-001-A), and mouse IgG1-PE conjugate (10 uL for LGR5 ...
-
bioRxiv - Neuroscience 2024Quote: ... and proximal colon and plasma lipocalin 2 (LCN2) (#MLCN20, R&D Systems Minneapolis, MN) were also performed according with the manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2023Quote: ... and 100 μM of dynole31-2 (negative control) (R&D Systems, Minneapolis, MN, USA) before or after illumination ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 μM Y-27632 and 2 ng/mL human recombinant BMP4 (R&D Systems) and then cultured in ultra-low attachment 6 well plate (Corning ...
-
bioRxiv - Microbiology 2023Quote: ... granzyme B (R&D Systems, Minneapolis, MN, USA), and perforin (abcam ...
-
bioRxiv - Cell Biology 2023Quote: ... rhTGF-β1 ligand (R&D Systems; 240-B) was added to the plates at a final well concentration of 2ng/mL for 0 and 30 min ...
-
bioRxiv - Cancer Biology 2023Quote: Recombinant human TGFβ1 (240-B R&D Systems) was stocked as 20 μg/ml in DMSO and AZ3146 (SML-1427 Sigma Aldrich ...
-
bioRxiv - Genetics 2021Quote: ... and 2 μg/ml of mouse anti-ACE2 (R&D Systems;; Catalogue: MAB933;; RRID: AB_2223153). Secondary antibodies used were ...
-
bioRxiv - Immunology 2021Quote: ... plates were blocked in 300 ml of 1x reagent diluent concentrate 2 (R&D Systems) for 1 h at RT ...
-
bioRxiv - Microbiology 2021Quote: ... Replacement of CHIR99021 by 20 ng/mL FGF-2 (223-FB-500, R&D Systems), followed by maintenance in 15 ng/mL VEGF and 5 ng/mL FGF-2 induced differentiation into the hematopoietic lineage according to a modified protocol from Grigoriadis et al ...
-
bioRxiv - Immunology 2021Quote: ... cells have been expanded using 20ng/ml mouse IL-2 (R&D System 402-ML). Cells were considered into exhaustion-like state after 4 stimulations (Tex ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with growth factors at the following concentrations: LM-22A4 (2 μM, R&D Systems), GDNF (2 ng/mL ...
-
bioRxiv - Systems Biology 2020Quote: ... supplemented with growth factors at the following concentrations: LM-22A4 (2 µM, R&D Systems), GDNF (2 ng/mL ...
-
bioRxiv - Developmental Biology 2022Quote: ... Samples were diluted at 2 μg/ml using Calibrator Diluent RD5-18 (R&D Systems). Hyaluronan quantification was then performed using the Hyaluronan Quantikine™ ELISA kit from R&D Systems (DHYAL0).
-
bioRxiv - Neuroscience 2022Quote: ... and 2 ng/ml recombinant human NRG1-β 1 (#396-HB, R&D Systems, USA) as described in Poitelon et al ...
-
bioRxiv - Molecular Biology 2022Quote: Human recombinant BMP-2 and BMP-4 were purchase from R&D Systems (Minneapolis, MN). Anti-Myc and anti-HA antibodies were purchased from Cell Signaling Technology (Danvers ...
-
bioRxiv - Cancer Biology 2022Quote: ... using additional reagents from the DuoSet ELISA ancillary reagent kit 2 (R&D Systems DY008). Briefly ...
-
bioRxiv - Immunology 2020Quote: ... isolated NK cells were cultured in 1000 IU/mL human IL-2 (R&D Systems) for 24 hours ...
-
bioRxiv - Bioengineering 2021Quote: ... Mouse anti-SARS-CoV-2 N monoclonal antibody (1:5000, R&D Systems, Cat#MAB10474) was used for the detection of SARS-CoV-2 ...
-
bioRxiv - Cancer Biology 2019Quote: ... the secretion levels of Matrix metallopeptidase (MMP)-2 and -9 (R&D system, MN, USA) and transforming growth factor (TGF)-β1 (R&D system ...
-
bioRxiv - Microbiology 2021Quote: ... cells were stimulated with increasing amounts of IFNs (α2 (R&D Systems, Cat#11101-2), β (R&D Systems ...
-
bioRxiv - Microbiology 2021Quote: ... cells were stimulated with increasing amounts of IFNs (α2 (R&D Systems, Cat#11101-2), β (R&D Systems ...
-
bioRxiv - Physiology 2020Quote: ... with 2 µg of recombinant human TSG-6 (rTSG-6, R&D Systems, Minneapolis, MN) in 100 µl PBS (or with PBS alone ...
-
bioRxiv - Developmental Biology 2019Quote: ... 10 uM SB431542 (SA) and 10 ng/mL recombinant human FGF-2 (R&D Systems) were added on D2 for 2 days ...
-
bioRxiv - Immunology 2022Quote: IL-4 complexes were generated by incubating 2 μg mouse rIL-4 (R&D Systems) with 10 μg LEAF purified anti-mouse IL4 antibody (clone 11B11 ...
-
bioRxiv - Systems Biology 2023Quote: ... Tube 2: rat monoclonal anti-human GSK-3B(Clone 272536, catalog # MAB2506, R&D Systems) and rabbit polyclonal anti-human Phospho-GSK-3BCatalog # AF1590 ...
-
bioRxiv - Immunology 2023Quote: ... were coated with human ACE-2 Fc chimera protein (R&D Systems cat# 10544-ZN) in cold PBS (100 μl per well ...
-
bioRxiv - Genetics 2023Quote: ... as per the manufacturer’s instructions (Mouse TGF-beta 2 Quantikine ELISA Kit, R&D Systems). The samples were diluted (1:80) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Secondary antibody was added for ULBP 1 and 2/5/6 only (R&D Systems). Cells were then washed and fixed in 4% paraformaldehyde ...
-
bioRxiv - Cancer Biology 2024Quote: ... at a 1:10 ratio and plated on 2-well comet slides (R&D Systems). Cells were then lysed overnight and immersed in alkaline unwinding solution as per manufacturer’s protocol (Trevigen) ...
-
bioRxiv - Molecular Biology 2022Quote: ... treated (‘+’) or not (‘-’) with dTAG-7 (R&D Systems) at the final concentration of 500 nM ...
-
bioRxiv - Molecular Biology 2022Quote: ... treated or not with dTAG-7 (R&D Systems) at the final concentration of 500 nM ...
-
bioRxiv - Bioengineering 2021Quote: ... 0.02µg/mL IL-7(R&D Systems, 207-IL), 0.01µg/mL IL-3 (R&D Systems ...
-
bioRxiv - Systems Biology 2021Quote: ... and mice fibroblast growth factor 7 (R&D system), 30μg/mL bovine pituitary extract (Gibco) ...
-
bioRxiv - Immunology 2020Quote: ... 5ng/mL each of IL-7 (R&D Systems) and IL-15 (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... or IL-7 (20 ng/mL; R&D Systems). After 24 hr (day 1) ...
-
bioRxiv - Immunology 2023Quote: ... with 7 µg IL-15Rα-Fc (R&D Systems) and incubating for 20-30 min at 37°C prior to injection ...
-
bioRxiv - Developmental Biology 2020Quote: ... 0.2 ng/mL TGFβ (R&D systems 240-B), or 1 ng/mL PTH aa1-34 (R&D systems 3011/1 ...
-
bioRxiv - Biochemistry 2019Quote: Cathepsin B (CTSB, 0.4 μg/μL, R&D Systems) was diluted in activation buffer (25 mM MES ...
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml TGFβ (R&D Systems #240-B) + 10 ng/ml EGF.
-
bioRxiv - Immunology 2021Quote: ... MICA/B-Alexa Fluor 700 (159207) (R&D Systems); anti-mouse CD3e-PerCP (145-2C11) ...
-
bioRxiv - Immunology 2020Quote: ... b) canine IL-4 (R&D Systems, Minneapolis, USA) at 125 ...
-
bioRxiv - Cancer Biology 2021Quote: ... 1x Energy regeneration solution (#B-10 R&D systems), 75 mM ubiquitin (#U-100H R&D systems ...
-
bioRxiv - Molecular Biology 2022Quote: ... 5ng/ml TGFβ (R&D systems, 240-B-002) was given ...
-
bioRxiv - Cell Biology 2024Quote: ... TGFB 10 ng/ml (R&D Systems #240-B), EGF 10 ng/ml + OSM 10 ng/ml ...
-
bioRxiv - Immunology 2021Quote: ... TF-I cells medium contained 2 ng/ml of recombinant human GM-CSF (R&D Systems). Cells have been cultured for no longer than 4 weeks after thawing and were regularly tested for Mycoplasma contamination using PCR technique and were confirmed to be negative.
-
bioRxiv - Molecular Biology 2020Quote: ... and TNF-α-treated CM with FGF-2 neutralizing antibody (NAb; AF-233, R&D Systems). On day 7 ...
-
bioRxiv - Molecular Biology 2021Quote: ... Samples were immuno-precipitated with 2-5 µg of either anti-GFI1 (AF3540, R&D systems), anti-H3K4me1 (ab8895 ...
-
bioRxiv - Neuroscience 2019Quote: ... and BSA (2%) and stained with following primary antibodies: PI16 (1:75, R&D Systems AF4929), GLUT1 (1:250 ...